ā€œWe started with an idea: applying food technologies to pharmaceuticals. As our research advanced, those initial insights, backed by clinical studies and real-world work, turned into certainties. And those certainties have now become our patents.ā€

Germano Tarantino, PharmaNutra Group Scientific Manager

Scientific research

Scientific research is the driving force behind PharmaNutra Group, powering the innovation and success of its products. The Group has always been dedicated to developing state-of-the-art solutions, blending a rigorous scientific approach with a forward-thinking attitude toward technology and patents.

The extensive clinical studies, fundamental research and published works have enabled the Group’s companies to acquire world-class technical and scientific expertise, leading to the recognition of innovative patents and the development of proprietary raw materials.

This represents a unique value and a key strategic asset, one that forms the foundation for PharmaNutra’s continued commitment to a future where scientific progress serves the collective well-being, focusing on prevention and health care.

Research focus

The Group's research focuses on several key areas of health, with particular attention paid to:

Nutritional deficiencies

Development of advanced solutions to enhance the absorption and bioavailability of essential micronutrients, made unique and effective through proprietary technologies like SucrosomialĀ® Technology.

Joint and muscle well-being

Innovation in products aimed at mobility and physical recovery, with applications in both medical and sports fields, supported by patents related to the functional principle of Cetylated Fatty Acids (CFAs).

Functional and sports nutrition

Research and development of high-quality nutritional solutions designed to address clinical imbalances or specific physiological needs, helping individuals achieve optimal health.

Body composition analysis

Through Akern S.r.l., the Group is a leader in bioelectrical impedance analysis, offering precise diagnostic tools to monitor overall health.

Exclusive technologies

The PharmaNutra Group is proud to hold patented technologies, which serve as a unique competitive advantage in the sector

SucrosomialĀ® Technology

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds. This innovative patent utilises a revolutionary and unique lipid structure, known as sucrosomeĀ®, to protect micronutrients from gastric acid, transport them to the intestine and enhance their absorption. The key benefits of this technology include improved tolerability, high absorption and clinical versatility.

Find out more
Functional ingredient of Cetylated Fatty Acids (CFAs)

Patented formulations designed to support joint and muscle mobility, recognised for their clinically proven beneficial effects. This patented functional ingredient is based on a specific blend of Cetylated Fatty Acids (CFA) — natural molecules with well-documented lubricating properties — which act deeply without side effects or doping concerns.
Key strengths of this patented technology include high skin penetration and an increased absorption rate of the active ingredient, enabling fast relief and the restoration of mobility.
Cetylated Fatty Acids are widely used in both topical and oral formulations, with clinical studies confirming their effectiveness in both sports and medical fields.

Find out more
Akern bioelectrical impedance technologies

Cutting-edge medical tools and software for body composition analysis using advanced bioelectrical impedance technologies (BIA). This non-invasive method measures the body's bioelectrical parameters to assess health status and tissue composition. The advantages of Akern technologies include diagnostic accuracy, a wide range of applications in both clinical and sports fields, and advanced digital systems that provide real-time data along with practical insights for doctors and health professionals.

Find out more

Patents and collaborations

PharmaNutra holds numerous international patents that protect the uniqueness of its solutions and ensure a strong market positioning. The company actively collaborates with research institutes, universities and hospitals to conduct clinical studies and develop new applications in the fields of nutraceuticals and diagnostics.

Impact and continuous innovation

Thanks to a team of highly skilled researchers and continuous investments in R&D, the PharmaNutra Group can anticipate market needs and offer products that blend scientific efficacy with quality recognised by customers. This commitment to innovation allows the Group to make significant contributions to scientific progress and the improvement of global health.